Climb Bio Inc（CLYM）价格预测

$10.125

+0.587 (+5.80%)收盘时

价格预测

1-Day Price Prediction

+0.29%

1-Week Prediction

-1.89%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

CLYM 相似图表分析预测

Alphio's CLYM stock price prediction model matches the current Climb Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.15 (+0.29%). The 1-week path is $9.93 (-1.89%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Climb Bio Inc 股票吗？

Climb Bio Inc (CLYM) is a good buy right now due to its promising clinical trial results for CLYM116, which demonstrated over 90% APRIL suppression, and the strong cash position of $239.2 million that supports ongoing R&D. The current price of $10.19 is well below the analyst price targets, with the highest target at $32, suggesting a potential upside of over 200%. However, the company reported a net income loss of $13.7 million in Q1 2026, which poses a risk to profitability.

CLYM 股价于 Wednesday 收于 $10.13，此前上涨 +5.80%

Climb Bio Inc (CLYM) last closed at $10.125, gaining +5.80%. These facts feed the 1-day and 1-week CLYM price prediction above.

预测驱动因素

Climb Bio Inc（CLYM）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 CLYM 最接近的股票，按相似度排序。

ISRG

91.01%

-3.11%

SES

90.93%

-10.51%

OGN

90.76%

+115.80%

PODD

90.61%

-15.37%

RPM

90.50%

-5.16%

CLYM 季节性分析

Historically the probability of a positive October return for CLYM is 72.73%. September offers the highest probability of a positive month at 93.55%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…